Fracture Preventing Effects of Maxmarvil® Tablets (Alendronate 5 mg + Calcitriol 0.5 µg) in Patients with Osteoporosis

BACKGROUND: The purpose of this prospective, open-label, observational study was to assess the fracture preventing effect of Maxmarvil® tablets (alendronate 5 mg + calcitriol 0.5 µg) in patients with osteoporosis and to evaluate the change in bone mineral density (BMD) at the minimum 1-year follow-u...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Bone Metab
Principais autores: Yoo, Jun-Il, Ha, Yong-Chan, Won, Ye-Yeon, Yang, Kyu-Hyun, Kim, Sang-Bum, Yoo, Ju-Hyung, Kim, Dong-Soo
Formato: Artigo
Idioma:Inglês
Publicado em: The Korean Society for Bone and Mineral Research 2017
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5472803/
https://ncbi.nlm.nih.gov/pubmed/28642852
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.11005/jbm.2017.24.2.91
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados